Association of CYP1B1 gene polymorphisms and the positive expression of estrogen α and estrogen β with endometrial cancer risk

European Journal of Gynaecological Oncology

Volumn 32, Issue 2, 2011, Pages 188-191

  Zhu, Z Y ^a   Mu, Y Q ^a   Fu, X M ^a   Li, S M ^a   Zhao, F X ^a  

^a SHANXI DATONG UNIVERSITY   (China)

Author keywords

Endometrial cancer; ER and ER ; L432V polymorphism of CYP1B1 gene; Risk factor

Indexed keywords

CYTOCHROME P450 1B1; ESTROGEN; ESTROGEN ALPHA; ESTROGEN BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; CONTROLLED STUDY; ENDOMETRIUM CANCER; EXON; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATION; POLYMERASE CHAIN REACTION; WILD TYPE;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; ALLELES; ARYL HYDROCARBON HYDROXYLASES; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK;

EID: 79955700284     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Buchanan E.M., Weinstein L.C., Hillson C.: "Endometrial cancer". Am. Farn. Physician, 2009, 80, 1075.
2. Linkov F., Edwards R., Balk J., Yurkovetsky Z., Stadterman B., Lokshin A., Taioli E.: "Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors". Eur. J. Cancer, 2008, 44, 1632.
3. Purdie D.M., Green A.C.: "Epidemiology of endometrial cancer". Best Pract. Res. Clin. Obstet. Gynaecol., 2001, 15, 341.
4. Tsuchiya Y., Nakajima M., Yokoi T.: "Cytochrome P450-mediated metabolism of estrogens and its regulation in human". Cancer Lett., 2005, 227, 115.
5. Goodman M.T., McDuffie K., Kolonel L.N., Terada K., Donlon T.A., Wilkens L.R. et al.: "Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism". Cancer Epidemiol. Biomarkers Prev., 2001, 10, 209.
6. Tsuchiya Y., Nakajima M., Kyo S, Kanaya T, Inoue M., Yokoi T.: "Human CYP1B1 is regulated by estradiol via estrogen receptor". Cancer Res., 2004, 64, 3119.
7. Sasaki M., Kaneuchi M., Fujimoto S., Tanaka Y., Dahiya R.: "CYP1B1 gene in endometrial cancer". Mol. Cell Endocrinol., 2003, 202, 171.
8. Zhu Z.Y., Mi R.R., Liu J.: "Association between gene polymorphism of CYP1B1 and susceptibility to ovarian cancer". Progress Obstet. Gynecol., 2006, 15, 184.
9. Tanaka Y., Sasaki M., Kaneuchi M., Shiina H., Igawa M., Dahiya R.: "Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer". Biochem. Biophys Res. Commun., 2002, 296, 820.
10. Okobia M.N., Bunker C.H., Garte S.J., Zmuda J.M., Ezeome E.R., Anyanwu S.N. et al.: "Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study". Infect. Agent Cancer, 2009, 4 (suppl. 1), S12.
11. Daayana S., Holland C.M.: "Hormone replacement therapy and the endometrium". Menopause Int., 2009, 15, 134.
12. Potischman N., Hoover R.N., Brinton L.A., Siiteri P., Dorgan J.F., Swanson C.A. et al.: "Case-control study of endogenous steroid hormones and endometrial cancer". J. Natl. Cancer Inst., 1996, 88, 1127-35. (Pubitemid 26274607)
13. Allen N.E., Key T.J., Dossus L., Rinaldi S., Cust A., Lukanova A. et al.: Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)". Endocr. Relat. Cancer, 2008, 15, 485.
14. Tang Y.M., Wo Y.Y., Stewart J., Hawkins A.L., Griffin C.A., Sutter T.R., Greenlee W.F.: "Isolation and characterization of the human cytochrome P450 CYP1B1 gene". J. Biol. Chem., 1996, 271, 28324.
15. Lewis D.F., Gillam E.M., Everett S.A., Shimada T.: "Molecular modelling of human CYP1B1 substrate interactions and investigation of allelic variant effects on metabolism". Chem. Biol. Interact., 2003, 145, 281.
16. Rylander T., Wedren S., Granath F.: "Cytochrome P4501B1 gene polymorphisms and postmenopausal breast cancer risk". Carcinogenesis, 2003, 24, 1533.
17. Zimarina T.C., Kristensen V.N., Imianitov E.N.: "Polymorphism of CYP1B1 and COMT in breast and endometrial cancer". Mol. Biol., 2004, 38, 386.
18. Doherty J.A., Weiss N.S., Freeman R.J., Dightman D.A., Thornton P.J., Houck J.R. et al.: "Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer". Cancer Epidemiol. Biomarkers Prev., 2005, 14, 357.
19. Sobti R.C., Onsory K., Al-Badran A.I., Kaur P., Watanabe M., Krishan A., Mohan H.: "CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population". DNA Cell. Biol., 2006, 25, 287.
20. Cecchin E., Russo A., Campagnutta E., Martella L., Toffoli G.: "Lack of association of CYP1 B1*3 polymorphism and ovarian cancer in a Caucasian population". Int. J. Biol. Markers, 2004, 19, 160.
21. Huber A., Bentz E.K., Schneeberger C., Huber J.C., Hefler L., Tempfer C.: "Ten polymorphisms of estrogen-metabolizing genes and a family history of colon cancer-an association study of multiple gene-gene interactions". J. Soc. Gynecol. Investig., 2005, 12, e51.
22. Yao L., Fang F., Wu Q., Zhong Y., Yu L.: "No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects". Breast Cancer Res. Treat., 2009.
23. Sasaki M., Tanaka Y., Kaneuchi M., Sakuragi N., Dahiya R.: "CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions". Cancer Res., 2003, 63, 3913.
24. Hanna I.H., Dawling S., Roodi N., Guengerich F.P., Parl F.F.: "Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity". Cancer Res., 2000, 60, 3440.
25. Lee K.M., Abel J., Ko Y., Harth V., Park W.Y., Seo J.S. et al.: "Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women". Br. J. Cancer, 2003, 88, 675.
26. Esinler I., Aktas D., Alikasifoglu M., Tuncbilek E., Ayhan A.: "CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma". Int. J. Gynecol. Cancer, 2006, 16, 1407.
27. Mikhailova O.N., Gulyaeva L.F., Prudnikov A.V., Gerasimov A.V., Krasilnikov S.E.: "Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk". Pharmacogenomics J., 2006, 6, 189.